MBOT Earnings & Financial Statements
Microbot Medical Inc.
$1.07
$0.00(0.00%)
31
Overall
60
Value
9
Tech
26
Quality
Market Cap
$71.87M
Volume
599.69K
52W Range
$1.14 - $3.46
Target Price
$8.00
MBOT earnings and financial statements: Microbot Medical Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MBOT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of revenue | - | - | - | $4.56M | $3.88M |
| Operating income | -$14.74M | -$11.63M | -$9.86M | -$13.28M | -$11.36M |
| EBITDA | -$14.38M | -$11.53M | -$10.63M | -$13.34M | -$11.28M |
| Net income | -$13.14M | -$11.44M | -$10.74M | -$13.17M | -$11.31M |
| EPS (diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $81.54M | $6.03M | $8.33M | $9.54M | $16.77M |
| Total liabilities | $3.99M | $2.50M | $3.83M | $2.25M | $2.39M |
| Shareholders’ equity | $77.55M | $3.53M | $4.50M | $7.29M | $14.38M |
| Cash and equivalents | $3.91M | $3.11M | $2.47M | $2.44M | $13.49M |
| Long-term debt | $569.0K | $41.0K | $40.0K | $179.0K | $402.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.05M | -$8.83M | -$8.53M | -$11.55M | -$9.35M |
| Capital expenditure | -$60.0K | -$25.0K | -$33.0K | -$84.0K | -$69.0K |
| Free cash flow | -$13.11M | -$8.85M | -$8.57M | -$11.63M | -$9.42M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBOT | $1.07 | 0% | 599.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |